Year archive

Nirvana Life Sciences Inc — 2024 filings

All 16 regulatory filings released by Nirvana Life Sciences Inc (NIRV) in 2024, sourced directly from the official regulator.

16 Filings

2024 Period

2024 filings (16)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-12-31	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-12-31	English
Interim MD&A - English.pdf Management Reports	2024-12-31	English
Interim financial statements/report – English.pdf Interim / Quarterly Report H1 2025	2024-12-31	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-12-05	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-12-05	English
Interim MD&A - English.pdf Management Reports	2024-12-05	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2024-12-04	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2024-12-04	English
Annual MD&A - English.pdf Management Reports	2024-12-04	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-12-04	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2024	2024-12-04	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-04-02	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-04-02	English
Interim MD&A - English.pdf Regulatory Filings	2024-04-02	English
Interim financial statements/report – English.pdf Regulatory Filings	2024-04-02	English